Abstract
Designing highly selective molecules for a drug target protein is a challenging task in drug discovery. This task can be regarded as a multiobjective problem that simultaneously satisfies a criteria of various objectives, such as selectivity for a target protein, pharmacokinetics endpoints, and drug-like indices. Recent breakthroughs in artificial intelligence have accelerated the development of molecular structure generation methods, and various researchers have applied them to computational drug designs and successfully proposed promising drug candidates. However, designing efficient selective inhibitors with releasing activities against various homologs of a target protein remains a difficult issue. In this study, we developed a de novo structure generator based on reinforcement learning that is capable of simultaneously optimizing multiobjective problems. Our structure generator successfully proposed selective inhibitors for tyrosine-kinases while optimizing 18 objectives consisting of the inhibitory activities against nine tyrosine kinases, three pharmacokinetics endpoints, and six other important properties. These results show that our structure generator and optimization strategy for selective inhibitors will contribute to the further development of practical structure generators for drug designs.
Supplementary materials
Title
Supporting Information for Selective Inhibitor Design for Kinase Homologs Using Multiobjective Monte Carlo Tree Search
Description
Correlation plots of predicted objective values and corresponding experimenetal values; scaling functions for each objective; processes of molecule generation by the proposed method for selective inhibitors targeting kinase homologs; processes of molecule generation by the proposed method for selective inhibitors targeting EGFR and BACE1; correlation matrix between prediction models; twenty examples of generated selective inhibitors with high Dscores targeting EGFR and their predicted properties.
Actions